Spigset O - Search Results

1

Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.

Hägg S, Spigset O, Lakso HA, Dahlqvist R. Hägg S, et al. Among authors: spigset o. Eur J Clin Pharmacol. 2001 Sep;57(6-7):493-7. doi: 10.1007/s002280100343. Eur J Clin Pharmacol. 2001. PMID: 11699614 Clinical Trial.

2

Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans.

Spigset O, Carleborg L, Hedenmalm K, Dahlqvist R. Spigset O, et al. Clin Pharmacol Ther. 1995 Oct;58(4):399-403. doi: 10.1016/0009-9236(95)90052-7. Clin Pharmacol Ther. 1995. PMID: 7586931

3

[A regional center for reporting adverse drug reactions in Umeå. Prompt handling results in quick feedback].

Bäckström M, Dahlqvist R, Mjörndal T, Spigset O, Hedenmalm K, Granberg K, Oqvist U, Wiholm BE. Bäckström M, et al. Among authors: spigset o. Lakartidningen. 1995 Jan 18;92(3):148-50. Lakartidningen. 1995. PMID: 7837847 Swedish. No abstract available.

4

[Depression caused by beta blockaders. Unknown mechanisms behind well-known adverse effects].

Hägg S, Håkansson J, Spigset O. Hägg S, et al. Among authors: spigset o. Lakartidningen. 1995 Dec 6;92(49):4681-3. Lakartidningen. 1995. PMID: 8531528 Swedish. No abstract available.

5

Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms.

Spigset O, Granberg K, Hägg S, Norström A, Dahlqvist R. Spigset O, et al. Eur J Clin Pharmacol. 1997;52(2):129-33. doi: 10.1007/s002280050261. Eur J Clin Pharmacol. 1997. PMID: 9174682

6

Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors.

Spigset O, Hedenmalm K, Dahl ML, Wiholm BE, Dahlqvist R. Spigset O, et al. Acta Psychiatr Scand. 1997 Nov;96(5):379-84. doi: 10.1111/j.1600-0447.1997.tb09933.x. Acta Psychiatr Scand. 1997. PMID: 9395157

7

Urinary excretion of codeine, ethylmorphine, and their metabolites: relation to the CYP2D6 activity.

Hedenmalm K, Sundgren M, Granberg K, Spigset O, Dahlqvist R. Hedenmalm K, et al. Among authors: spigset o. Ther Drug Monit. 1997 Dec;19(6):643-9. doi: 10.1097/00007691-199712000-00007. Ther Drug Monit. 1997. PMID: 9421105

8

Non-linear fluvoxamine disposition.

Spigset O, Granberg K, Hägg S, Söderström E, Dahlqvist R. Spigset O, et al. Br J Clin Pharmacol. 1998 Mar;45(3):257-63. doi: 10.1046/j.1365-2125.1998.00670.x. Br J Clin Pharmacol. 1998. PMID: 9517369 Free PMC article. Clinical Trial.

9

Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.

Hägg S, Joelsson L, Mjörndal T, Spigset O, Oja G, Dahlqvist R. Hägg S, et al. Among authors: spigset o. J Clin Psychiatry. 1998 Jun;59(6):294-9. doi: 10.4088/jcp.v59n0604. J Clin Psychiatry. 1998. PMID: 9671341

10

[3H]GBR 12935 binding in platelets from poor and extensive cytochrome P-4502D6 metabolizers.

Norlén M, Norström A, Spigset O, Allard P. Norlén M, et al. Among authors: spigset o. Eur J Pharmacol. 1999 Feb 5;366(2-3):329-32. doi: 10.1016/s0014-2999(98)00935-2. Eur J Pharmacol. 1999. PMID: 10082215 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters